However, some randomized studies have demonstrated a lower incidence and grade of ILD caused by EGFR TKI in combination therapy with VEGF/VEGFR inhibitors than in monotherapy, although the underlying reasons are still unknown (24, 30). The gene discussed is KDR; the disease is interstitial lung disease.